Go beyond total cholesterol. Enter your lipid panel to calculate TG/HDL ratio, non-HDL cholesterol, and ApoB risk — the markers that actually predict cardiovascular disease.
Recommended — ask your doctor to add ApoB to your next lipid panel. It's the most accurate measure of cardiovascular risk.
Standard LDL-C measures the cholesterol content inside LDL particles — but it's actually the number of particles that matters. Two people can have the same LDL-C of 120 mg/dL while one has 800 large fluffy LDL particles (lower risk) and the other has 1,400 small dense particles (much higher risk). ApoB fixes this by counting one protein per atherogenic particle — every LDL, VLDL, IDL, and Lp(a) gets counted.
The research: Multiple meta-analyses show ApoB outperforms LDL-C as a predictor of cardiovascular events, especially in metabolic syndrome, insulin resistance, and high-triglyceride states. The European Atherosclerosis Society now recommends ApoB as the primary treatment target.
Target: For most people, ApoB below 90 mg/dL is the optimal goal. High-risk patients (prior heart attack, diabetes, FH) should aim for ApoB below 70 mg/dL.
The triglyceride-to-HDL ratio is one of the best surrogate markers for insulin resistance available on a standard lipid panel. When insulin resistance develops, the liver overproduces VLDL (raising triglycerides) while HDL levels fall in parallel — driving the ratio upward.
What it predicts: A TG/HDL ratio above 3.5 strongly correlates with small dense LDL particles (pattern B), elevated HOMA-IR, visceral fat accumulation, and significantly higher cardiovascular risk — even when LDL-C appears normal. Studies show TG/HDL > 3.5 predicts insulin resistance with ~85% sensitivity.
How to improve it: Reduce refined carbohydrates and sugar (lowers TG), increase omega-3 fatty acids, exercise regularly (raises HDL), optimize sleep (poor sleep raises TG), and lose visceral fat. These interventions often move TG/HDL more than statins alone.
Non-HDL-C (total cholesterol minus HDL) is calculated directly from your basic lipid panel with no additional cost. It captures all atherogenic lipoproteins — not just LDL but also VLDL, IDL, and remnant particles that LDL-C misses. The American Heart Association now lists non-HDL as a preferred secondary target after LDL-C, with a goal below 130 mg/dL.
Track your cholesterol trends over time
Upload your lab results to Vitalix and track ApoB, TG/HDL ratio, and non-HDL trends alongside medications, supplements, and lifestyle experiments. AI recommends which tests to add next.
Start Tracking FreeAlso check your insulin resistance
TG/HDL ratio and HOMA-IR together give a complete metabolic picture
This calculator is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for interpretation of lab results and treatment decisions.